A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms
Sign Up to like & getrecommendations! Published in 2024 at "Experimental Biology and Medicine"
DOI: 10.3389/ebm.2024.10021
Abstract: The presence of inhibitory immune cells and difficulty in generating activated effector T cells remain obstacles to development of effective cancer vaccines. We designed a vaccine regimen combining human telomerase reverse transcriptase (hTERT) peptides with… read more here.
Keywords: phase trial; telomerase reverse; transcriptase htert; vaccination ... See more keywords